Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
03/06/2003 | WO2003018804A1 Proteins having effects of controlling cell migration and cell death |
03/06/2003 | WO2003018801A1 Cd36/fat gene promoter and diagnosis of disease associated with cd36/fat gene |
03/06/2003 | WO2003018799A2 Modulators of bone homeostasis identified in a high-throughput screen |
03/06/2003 | WO2003018798A2 G-protein coupled receptor and dna sequences thereof |
03/06/2003 | WO2003018796A1 Oxidative dehalogenation enzyme gene useful for synthesis of optically active 1,2-diol and halogenohydrin and method of mass expression thereof |
03/06/2003 | WO2003018794A1 α-1,2-FUCOSYL TRANSFERASE AND DNA ENCODING THE SAME |
03/06/2003 | WO2003018788A2 Improved nitroreductase enzymes |
03/06/2003 | WO2003018778A2 Method for preparing a freeze-dried composition containing lactic acid bacteria with enhanced bacterial viability and activity during storage at room temperature and resulting composition |
03/06/2003 | WO2003018777A1 A universal light-switchable gene promoter system |
03/06/2003 | WO2003018771A2 A system for antibody expression and assembly |
03/06/2003 | WO2003018768A2 Transmembrane protein differentially expressed in cancer |
03/06/2003 | WO2003018766A2 Self-processing plants and plant parts |
03/06/2003 | WO2003018764A2 Novel human proteases and polynucleotides encoding the same |
03/06/2003 | WO2003018759A2 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same |
03/06/2003 | WO2003018758A2 Reagents and methods for smooth muscle therapies |
03/06/2003 | WO2003018756A2 Methods for preparing purified prostaglandin e synthase |
03/06/2003 | WO2003018754A2 Neural regeneration peptide and methods for their use in treatment of brain damage |
03/06/2003 | WO2003018636A2 Chimaeric peptides of insulin, their compositions and use in treating diabetes |
03/06/2003 | WO2003018631A2 Nogo receptor homologues and their use |
03/06/2003 | WO2003018626A2 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton |
03/06/2003 | WO2003018612A2 Extracellular messengers |
03/06/2003 | WO2003018052A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments |
03/06/2003 | WO2003017935A2 Human antibodies specific for interleukin 15 (il-15) |
03/06/2003 | WO2003006069A9 Imaging infection using fluorescent protein as a marker |
03/06/2003 | WO2003002131B1 Strain of micro-organism lactobacillus fermentum me-3 as novel anti-microbial and antioxidative probiotic |
03/06/2003 | WO2002095036A8 A novel intein and uses thereof |
03/06/2003 | WO2002088327A9 Methods for viral oncoapoptosis in cancer therapy |
03/06/2003 | WO2002088178A8 Antigens of group b streptococcus and corresponding dna fragments |
03/06/2003 | WO2002086097A3 Methods for identifying the target of a compound which inhibits cellular proliferation |
03/06/2003 | WO2002086069A3 Secreted proteins |
03/06/2003 | WO2002085945A3 Vhh single heavy chain antibody and a method for its preparation in a mammal |
03/06/2003 | WO2002081709A3 Modified hpv e6 and e7 genes and proteins useful for vaccination |
03/06/2003 | WO2002064731A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
03/06/2003 | WO2002062959A3 Hepatitis b virus treatment |
03/06/2003 | WO2002060929A3 Polymer conjugates of neublastin and methods of using same |
03/06/2003 | WO2002059302A3 Regulation of human serotonin-like g protein-coupled receptor |
03/06/2003 | WO2002051994A8 Polypeptides |
03/06/2003 | WO2002043661B1 Recombinant anti-cd30 antibodies and uses thereof |
03/06/2003 | WO2002031151A3 Lipocalins |
03/06/2003 | WO2002026947A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
03/06/2003 | WO2002022678A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
03/06/2003 | WO2002016421A3 Altered ospa of borrelia burgdorferi |
03/06/2003 | WO2002014500A3 Human genes and gene expression products |
03/06/2003 | WO2002012325A3 Suppressor gene |
03/06/2003 | WO2002006478A8 Extracellular matrix protein |
03/06/2003 | WO2002002602A9 Slgp protein and nucleic acid molecules and uses therefor |
03/06/2003 | WO2001098343A9 Conserved diaphanous-related formin autoregulatory domain (dad) |
03/06/2003 | WO2001092304A3 Transporters and ion channels |
03/06/2003 | WO2001086293A8 A method for designing and screening random libraries of compounds |
03/06/2003 | WO2001080880A8 Apoptotic agents |
03/06/2003 | WO2001072781A9 Human genes and expression products |
03/06/2003 | WO2001066741A9 Kcnb: a novel potassium channel protein |
03/06/2003 | WO2001062924A9 Human g protein-coupled receptors |
03/06/2003 | WO2001055393A9 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
03/06/2003 | US20030045711 Epothilone derivatives and methods for making and using the same |
03/06/2003 | US20030045702 Secreted Chlamydia polypeptides and method for identifying such polypeptides by their secretion by a type III secretion pathway of a gram-negative bacteria |
03/06/2003 | US20030045701 Polynucleotide constructs and methods of expression in a host cell |
03/06/2003 | US20030045695 Ribozyme for detecting gene sequence |
03/06/2003 | US20030045691 Reshaped human anti-hm 1.24 antibody |
03/06/2003 | US20030045686 Mutein polypeptide for use in the treatment of hypoxia and ischemic related tissue damages |
03/06/2003 | US20030045684 Polypeptide for use in humans therapeutics and diagnostics |
03/06/2003 | US20030045479 Novel N-formyl hydroxylamine compounds, compositions and methods of use |
03/06/2003 | US20030045466 Calcium binding protein |
03/06/2003 | US20030045438 Proteases from gram positive organisms |
03/06/2003 | US20030044965 Composition for the preservation of bacteria in a viable state in culture |
03/06/2003 | US20030044955 Expression vector for use as tool in the transfer and expression of heterologous polypeptides in fungi |
03/06/2003 | US20030044951 Bio-reaction process and product |
03/06/2003 | US20030044950 Phosphodiesterase 10 |
03/06/2003 | US20030044947 Nucleotide sequences coding polypeptide for use in controlling methanol metabolism in yeast |
03/06/2003 | US20030044943 Process for the production of L-amino acids by fermentation using coryneform bacteria |
03/06/2003 | US20030044939 Process and materials for production of glucosamine |
03/06/2003 | US20030044937 Nucleotide sequences coding polypeptide for use in the treatment of inflammation and cancer |
03/06/2003 | US20030044913 Extracellular matrix and cell adhesion molecules |
03/06/2003 | US20030044912 KCNQ potassium channels and methods of modulating same |
03/06/2003 | US20030044910 Nucleotide sequences coding membrane protein for use in the treatment and prevention of viral and tumor diseases |
03/06/2003 | US20030044906 Nucleic acids, proteins, and processes for producing proteins such as fusion proteins for the secretion of a protein of interest into bacterial supernatants |
03/06/2003 | US20030044894 Sterilizing of transformed microorganism; generation nutrient broth, inoculate with microorganism, heat, express vector, recover heat resistant protein |
03/06/2003 | US20030044893 Nectin polypeptides, polynucleotides, methods of making and use thereof |
03/06/2003 | US20030044886 Generation of carotenoid compounds in culture; obtain genetically engineered microorganism, culture under conditions which generate carotenoids, recover products |
03/06/2003 | US20030044851 Secreted protein HCEJQ69 |
03/06/2003 | US20030044823 Reagents and methods for automated hybridization |
03/06/2003 | US20030044807 Rhodococcus cloning and expression vectors |
03/06/2003 | US20030044783 Human genes and gene expression products |
03/06/2003 | US20030044423 Particularly relates to antibodies and fusion proteins in which a hinge region derives from one isotype and the CH2 domain derives from a different isotype |
03/06/2003 | US20030044422 Ehrlichia ruminantium polypeptides, antigens, polynucleotides, and methods of use |
03/06/2003 | US20030044403 Anti-infective therapy |
03/06/2003 | US20030044386 Genetic engineering; nucleic acid coding cytokines |
03/06/2003 | CA2458866A1 Compositions and methods of treating diabetes |
03/06/2003 | CA2458574A1 Reagents and methods for smooth muscle therapies |
03/06/2003 | CA2458559A1 Gene of novel corynebacterium diphtheriae antigen |
03/06/2003 | CA2458512A1 .alpha.-1,2-fucosyl transferase and dna encoding the same |
03/06/2003 | CA2458445A1 Extracellular messengers |
03/06/2003 | CA2458381A1 Transmembrane protein differentially expressed in cancer |
03/06/2003 | CA2458226A1 Improved nitroreductase enzymes |
03/06/2003 | CA2458224A1 A universal light-switchable gene promoter system |
03/06/2003 | CA2458187A1 Method for producing vitamin b12 |
03/06/2003 | CA2457915A1 Novel human proteases and polynucleotides encoding the same |
03/06/2003 | CA2457879A1 Modulators of bone homeostasis identified in a high-throughput screen |
03/06/2003 | CA2457807A1 Ashbya gossypii enzymes |
03/06/2003 | CA2457779A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments |